RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/34137365http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/34137365http://www.w3.org/2000/01/rdf-schema#comment"

Objectives

This study aimed to evaluate serum otolin-1 levels in patients with benign paroxysmal positional vertigo and to compare these levels with healthy individuals.

Method

This was a case-control study. After obtaining institutional ethical committee clearance, the serum level of otolin-1 was calculated in adult individuals (18-75 years old) who were divided into group 1 (patients presenting with benign paroxysmal positional vertigo) and group 2 (healthy patients without benign paroxysmal positional vertigo as the control group). Data analysis was carried out to compare the serum levels in the cases and controls. A p-value less than 0.05 was considered significant.

Results

A total of 70 age-matched individuals (cases, n = 40; controls, n = 30) were included in the study. The mean serum level of otolin-1 was 636.8 pg/ml (range, 259-981 pg/ml) in the group of patients with benign paroxysmal positional vertigo and 236.2 pg/ml (range, 189-370 pg/ml) in the control group. The difference was statistically significant (p = 0.0000).

Conclusion

The serum levels of otolin-1 in patients with benign paroxysmal positional vertigo are significantly higher compared with individuals without benign paroxysmal positional vertigo."xsd:string
http://purl.uniprot.org/citations/34137365http://purl.org/dc/terms/identifier"doi:10.1017/s0022215121001274"xsd:string
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/author"Singh A."xsd:string
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/author"Kumar R."xsd:string
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/author"Ramakrishnan L."xsd:string
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/author"Verma H."xsd:string
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/author"Yadav H."xsd:string
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/author"Abraham R.A."xsd:string
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/author"Irugu D.V.K."xsd:string
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/name"J Laryngol Otol"xsd:string
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/pages"589-592"xsd:string
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/title"Serum otolin-1 as a biomarker for benign paroxysmal positional vertigo: a case-control study."xsd:string
http://purl.uniprot.org/citations/34137365http://purl.uniprot.org/core/volume"135"xsd:string
http://purl.uniprot.org/citations/34137365http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/34137365
http://purl.uniprot.org/citations/34137365http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/34137365
http://purl.uniprot.org/uniprot/#_A6NHN0-mappedCitation-34137365http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34137365
http://purl.uniprot.org/uniprot/A6NHN0http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/34137365